Search results
Author(s):
Sivadasanpillai Harikrishnan
Added:
3 years ago
“All diseases begin in the gut.”
– Hippocrates (460–370 BC)
In recent years many researchers have described the relationship between the gut microbiota and many diseases, including heart disease, hypertension, diabetes and obesity.1,2 Diet is one of the major factors that influence the pattern of the gut microbiota.3 This article discusses how the gut microbiota affects heart failure.
What is…
View more
Author(s):
Conor P Kerley
Added:
3 years ago
Heart failure (HF) is a major cause of hospitalisation, morbidity and mortality. Nutritional factors are major contributors to HF precursors, including hypertension, obesity, dyslipidaemia, insulin resistance/diabetes and systemic inflammation. Multiple landmark trials, including Dietary Approaches to Stop Hypertension (DASH)1 and Prevención con Dieta Mediterránea (PREDIMED),2 have documented the…
View more
Author(s):
Justin Ezekowitz
,
Harriette Van Spall
Added:
2 years ago
In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall(McMaster University, CA) meets PI, Dr Justin A. Ezekowitz (University of Alberta, CA) to discuss the SODIUM-HF trial (CT02012179). The aim of the trial was to evaluate the effects of a low-sodium diet, compared to usual care in patients with heart failure.
Presented first at ACC.22, the trial showed that reducing…
View more
Author(s):
Purvi Parwani
Added:
4 months ago
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.Trials discussed in detail include:POP-HT: Cardiac…
View more
Purvi Parwani
Research Area(s) / Expertise:
Job title: Cardiologist & Advanced Cardiovascular Imager
Author
Author(s):
Mary-Tiffany Oduah
,
Varun Sundaram
,
Yogesh Reddy
Added:
1 year ago
Robert Eckel
Job title: Professor of Medicine
Author
Added:
2 years ago
Controversy is good.But when it comes to hyperkalaemia management, we need solutions.
Chair, Prof Sydney Tang (University of Hong Kong, HK) Prof Chuan-Ming Hao(Huashan Hospital, CN) and Dr Kieran McCafferty(Queen Mary University London, UK) discuss the implementation of hyperkalaemia management strategies for patients with CKD in line with recent guidelines updates.
View more
Added:
6 months ago
Source:
AHA, Jordan Rance
The American Heart Association has announced eight late-breaking science sessions to be presented in Philadelphia from November 10th to November 13th. AHA is focussed on innovation in cardiovascular disease for scientists, clinicians, researchers and other healthcare professionals.
Among the event’s highlights are eight late-breaking trial sessions, as listed below.
Watch our coverage of…
View more
Author(s):
Pierpaolo Pellicori
,
Kuldeep Kaur
,
Andrew L Clark
Added:
3 years ago
Heart failure (HF) is one of the most common reasons for admission to hospital. It is associated with long in-patient stays, and has a high in-hospital and post-discharge morbidity and mortality, whether left ventricular ejection fraction (LVEF) is reduced (HFREF) or normal (HeFNEF).1,2 Congestion, or fluid overload, is a classic clinical feature of patients presenting with HF. In some patients,…
View more